The Professional Development Committee is responsible for the design and delivery of PraxisAuril training courses and materials. The Committee is formed of some of the most experienced senior staff from several of the leading technology/knowledge transfer organisations in the UK and experienced volunteer practitioners lead the training sessions.
The PraxisAuril office contact for the Training Committee team is Alasdair Cameron
Sue joined the university sector in 2002 initially as Director, Lifescience Enterprise at the University of Southampton and now as Head of Technology Transfer at the University of Bristol, following a career with AstraZeneca.
Whilst with AstraZeneca, Sue undertook a range of commercial roles in marketing (UK and international), corporate strategy (new and existing businesses), business development and general management. As Managing Director of a French subsidiary she turned it from loss making to profit in 2 years through a rigorous prioritisation and rationalisation process. She was responsible for the sale of a subsidiary in Chile to one of its customers, negotiating a good price while protecting staff and maintaining an appropriate supply arrangement.
Jennie is Head of Engaged Scholarship and Impact Lead in the Faculty of Business & Law, strategically leading new engagements and interdisciplinary work with society and business. She supports staff to develop research and knowledge exchange projects, through the Get That Grant programme, and multi-disciplinary research sandpits. Jennie is also Head of Accreditations and led the School's successful Business School Impact System (BSIS) assessment, working to embed impact principles and activities across the Faculty. Jennie has strong international partnerships and and is a Non-Executive Director of PraxisAuril, the UK's leading body for knowledge exchange professionals. She has won over £12m from the ESRC, AHRC, EPSRC, ERDF, Erasmus+ and others, and is Co-Investigator on the ESRC’s Good Employment Learning Lab.
Iain is Head of Cambridge Enterprise’s Life Sciences team at the University of Cambridge where he and his team work in fields as diverse as therapeutics, diagnostics, IVF, epigenetics and agritech. CE’s portfolio of products includes alemtuzumab (Sanofi), breast cancer markers (Brevagen) and mouse touch screen chambers (Campden Instruments). Spin-outs include Morphogenix, Mission Therapeutics, Cambridge Epigenetix, XO1 Therapeutics (sold to Janssen), Z-factor, Phoremost, Predictimmune, DIOSynVax and Storm Therapeutics. Iain led discussions with GSK in respect of the University of Cambridge–GSK open innovation drug discovery initiative based at the SBC and was the Cambridge lead for the Apollo Therapeutics Fund. Iain has been an active trainer for Praxis Courses since 2004.
David Brownlee is the Innovation Advisor for Health and Social Care (HSC) in N. Ireland, where he heads up the HSC Innovations regional service. David graduated with First Class honours and a PhD from Queens University, Belfast in the early 90’s. After a period of Medical Research Council funded post-doctoral research, he then moved into technology transfer at the University of Southampton, subsequently consolidating these skills at the University of Ulster, prior to taking up the current position of Innovation Advisor within the N. Ireland Health Service.
Over the past 10 years in HSC, he has been responsible for amongst other things; the creation and delivery of the "Supporting Innovation in the HSC “framework project, the roll-out and adoption of the Innovation Policy for HSC, securing funding for and development of the infrastructure of HSC Innovations as a regional service; and managing and commercialising a pipeline of varied technologies in the healthcare arena.
Within the technology transfer arena David is involved in all aspects of the innovation process, as well as strategic management of technology portfolios. His interests include knowledge exchange and commercialisation (KEC), intellectual asset management, research translation, assessing value (savings) of the introduction of healthcare technologies, technology management and innovation strategy.
He has served on the Life and Health Sciences Horizon Panel of MATRIX (the Northern Ireland Science Industry Panel which advises Government on the commercial exploitation of R&D and science and technology), NIHR-MRC Working Group for model agreements, Government led study to examine ways to maximise the commercial and economic Impact of the Northern Ireland publicly funded research base, steering committee of the £25k (now INVENT) Entrepreneurship competition, and on various assessment panels including Knowledge Exchange and SBRI. David is also on the professional development committee of PraxisAuril, a world leading national professional association for public sector KEC practitioners - that drives the commercialisation of academic and public sector research for social and economic impact. He represents HSC in this important area of Innovation within the healthcare environment both nationally and internationally.
Phil is Commercialisation Director at Cambridge Enterprise where he partners life sciences technologies from the University of Cambridge with industry and investors. Phil joined Cambridge Enterprise from Cancer Research UK, where he spent over fifteen years working on the identification, protection, development and commercialisation of novel cancer therapeutics, ultimately as Head of Commercial Portfolio.
Whilst at Cancer Research UK, Phil established a partnership with Newcastle University, and notably worked for both organisations to build a strategic alliance with Astex Pharmaceuticals to discover and develop new cancer drugs. Phil also spent two and a half years as Chief Executive Officer of Demuris Limited, a Newcastle University spin out company focused on antibiotic drug discovery.
He has a PhD in developmental biology from the MRC’s National Institute for Medical Research (Mill Hill) and was a delegate on the very first PraxisAuril (then PraxisUnico) course held in Bristol in November 2002.
Dr Rich Ferrie is Director of Technology Transfer at University College Cork, having previously been Director of Operations and Head of UMIP - the technology transfer Division of UMI3 Ltd. He joined UMIP's predecessor company, MIL in 2000 after 11 years in various scientific and commercial roles with the diagnostics business of AstraZeneca culminating with leadership of its Sales and Marketing function internationally. A Biochemistry graduate (Sussex), Rich gained a PhD in Molecular Biology from the University of Reading. After a short period of post-doctoral research with the UK Forensic Science Service, Rich continued his work developing DNA fingerprinting technology for the Cellmark business unit of ICI Diagnostics. In 1991, Rich was appointed Technology Development Manager with responsibility for developing a platform of proprietary genetic technologies with diagnostic applications and is an inventor on 4 international patent applications. This work enabled the development of the first commercially available DNA-based cystic fibrosis diagnostic which was widely adopted. Between 1994 and 1997, Rich took a senior Business Development role developing commercial collaborations and relationships with businesses internationally, with a particular emphasis on the USA. From 1998 he established and led the Sales and Marketing department of Zeneca Diagnostics and was responsible for the inception and commercialisation of the ELUCIGENETM product range.
Paul Maclennan is a solicitor and a Partner at Anderson Law LLP, a niche firm of commercial/IP solicitors based in Oxfordshire. Paul advises on a wide variety of commercial agreements focussing on transactional work within the IT, life sciences and university sectors. His clients include leading UK universities and an international IT/telecoms company. Paul is listed in Chambers & Partners as a leading UK lawyer in the field of Intellectual Property and is a contributor to a number of Anderson Law’s publications on intellectual property and commercial law, most recently Technology Transfer (3rd Ed, Bloomsbury, 2010). Paul can be reached at email@example.com
Alistair McDermott is Director of Science led Services at Imperial College London where he is Executive Director of two subsidiary companies. Imperial Consultants, the commercial gateway to the academic expertise of Imperial College London, where he is responsible for increasing the number of academics undertaking consultancy projects at Imperial College whilst maintaining the university consulting service as a self-sustaining business. Imperial College Projects Limited, a company focused on developing and delivering long term commercial projects for Imperial College. He also oversees of the development and delivery of large research-based consortia projects. Alistair has worked for a number of universities and Research Councils supporting those institutions in expanding their research and commercial portfolios. He has been involved in the development of large national and international scientific research facilities and creating industry led research programmes. He has led regional businesses support initiatives, set up start-up centres and created joint ventures. Alistair has a degree and PhD in Material Science from the University of Sheffield and an MBA from the Open University.
Jeff is the Executive Director of the Institute of Innovation and Entrepreneurship at London Business School where he teaches others what he wishes someone had taught him 30 years ago and lives vicariously through his students’ manifold ventures.
Once upon a time he was Commercial Director at UCL where over 18 years he started and survived most of the now-commonplace KE units and mechanisms, ‘investing’ vast sums of government money which he was rather good at extracting. He was one of the founders of (and was once President of) both UNICO & ASTP. He’s been involved in Praxis and ATTP from inception, Chairing the Peer Recognition Panel of RTTP and never being asked to step down from the Professional Development Committee of Praxis. He does loads of training (probably more than anyone else) and talks to both Tech Transfer Managers and entrepreneurially-minded researchers all over the world. He runs a few seed funds, offers KT policy advice to governments and does KT audits for TTOs when they sound interesting.
A very long time ago he was an amateur thespian and secondary school teacher (which explains his love of the podium), spend years messing around in industry laboratories in the UK & US, did a PhD & MBA and spent a year on a ship prospecting for oil.
Gavin Smith, now retired, was Director of Lancaster University Business Enterprises Ltd. He was responsible for commercialisation of research from all departments of Lancaster University, including evaluations, patenting, marketing, licensing, spinout company formation and also using IP to assist in winning collaborative research grants.
Gavin was an undergraduate and postgraduate at Cambridge University. After a period as a post-doctoral researcher and then travelling, he spent many years in SMEs operating in the electronics, software and banking sectors, and as an independent consultant. He has been and continues to be a director of several university and independent companies.
Knowledge Exchange Profile: For the past 15 years Sarah has worked to promote knowledge exchange between HE and industry, her work has been focused on Cumbria and as such her specialist area of understanding is the growth and development of new Universities as place based anchor institutions in rural areas. All of her industry and knowledge exchange work has involved engagement with businesses across a range of sectors, with a specific understanding of the challenges of enabling knowledge exchange in rural areas with a primarily SME business profile. European Funding has enabled much the Knowledge Exchange work, as such Sarah has experience of managing and delivering programmes of over £24M of European structural funds.
Over the past 15 years Sarah has worked with and managed teams of up to 26 Knowledge Exchange professionals and as such has a keen interest in the advancement of knowledge exchange professional development frameworks.
Sarah’s most recent role has been as Business Development and Enterprise Lead for the University of Cumbria. She has sat on many regional boards encouraging links between Universities and regional growth this includes: Cumbria LEP Technical Officers Group, the Cumbria ESIF committee and the North West Universities European Unit. Sarah was very proud to be an AURIL council member from 2015.
Prior to joining the University of Leicester in July 2016 as the University’s Consultancy Manager, Josef was a Senior Project Manager for six years in the Oxford University Consulting (OUC) team at Oxford University Innovation, where he led a small team managing consultancy and services in medical and life sciences from the University of Oxford. Before this. Josef worked at a consultancy firm where he spent four and a half years providing support to pharmaceutical and biotech companies engaged in deal-making. He previously obtained his PhD in Immunology from University College London and spent time in post-doctoral research.
Stuart Wilkinson is Head of the Knowledge Exchange and Impact Team in the Research Services office of the University of Oxford. Stuart's current role is to support the University's engagement and partnership with external organisations across the institution to maximise the impact of the research, including regional partners including the LEP.
Previously Stuart worked as a consultant advising and training governments, companies and research organisations on technology development, intellectual property discovery, commercialisation strategy and business planning. Stuart also worked for Isis Innovation where he was responsible for evaluating, protecting and commercialising intellectual property in materials, engineering, energy and imaging technologies, including developing translational funding applications, business plans and negotiating investment for spin-out businesses. Stuart has a DPhil and MEng in BioMaterials and Materials Science from the University of Oxford.